Lecture 2 Pentose Phosphate Pathway
Lecture 2 Pentose Phosphate Pathway
Lecture 2
Pentose Phosphate Pathway
Christopher Larbie, PhD
In most animal tissues, glucose is catabolized via the glycolytic pathway into two
molecules of pyruvate. Pyruvate is then oxidized via the citric acid cycle to generate
ATP. There is another metabolic fate for glucose used to generate NADPH and
specialized products needed by the cell. This pathway is called the pentose
phosphate pathway. Some text books call it the hexose monophosphate shunt, still
others call it the phosphogluconate pathway.
The pentose phosphate pathway produces NADPH which is the universal reductant
in anabolic pathways. In mammals the tissues requiring large amounts of NADPH
produced by this pathway are the tissues that synthesize fatty acids and steroids
such as the mammary glands, adipose tissue, adrenal cortex and the liver. Tissues
less active in fatty acid synthesis such as skeletal muscle are virtually lacking the
pentose phosphate pathway.
6. Transketolase Reaction: This enzyme catalysis the transfer two carbon unit
from xylulose-5-P to ribose-5-P yielding 3-C unit glyceraldehyde-3-P and
sedoheptulose-7-P. The donor molecule is a ketone and the acceptor molecule
is an aldose. G-3-P enters the glycolytic pathway. Transketolase is dependent
on thiamine pyrophosphate as a cofactor. The mechanism involves the
abstraction of the acidic thiozole proton of TPP, attack by the resulting
carbanion at the carbonyl carbon of the ketose phosphate substrate, expulsion
of the G-3-P product, and transfer of the 2 C unit. Transketolase can process a
variety of 2-keto sugar substrates in a similar manner as in reaction 8.
Tailoring the Pentose Phosphate Pathway to meet specific needs of the cell
1. If the cell requires both ribose-5-P and NADPH, the first four reactions of the
PPP predominate. NADPH is produced by the oxidative reactions of the
pathway, and ribose-5-P is the principal product of carbon metabolism.
Xylulose-5-P also serves as a signalling molecule. When blood glucose levels rise,
glycolysis and PPP pathways are actvated in the liver and the X-5-P produced in the
latter pathways stimulate protein phosphate 2A (PP2A), which dephosphorylate the
bifunctional enzyme phosphofructokinase-2 or fructose-2,6-bisphosphatase.
The G6PD / NADPH pathway is the only source of reduced glutathione in red blood
cells (erythrocytes). The role of red cells as oxygen carriers puts them at substantial
risk of damage from oxidizing free radicals except for the protective effect of
G6PD/NADPH/glutathione.
People with G6PD deficiency are therefore at risk of haemolytic anaemia in states
of oxidative stress. Oxidative stress can result from infection and from chemical
exposure to medication and certain foods. Broad beans, e.g., fava beans, contain high
levels of vicine, divicine, convicine and isouramil, all of which are oxidants.
When all remaining reduced glutathione is consumed, enzymes and other proteins
(including haemoglobin) are subsequently damaged by the oxidants, leading
to electrolyte imbalance, cross-bonding and protein deposition in the red cell
Deficiency of G6PD in the alternative pathway causes the build-up of glucose and
thus there is an increase of advanced glycation end-products (AGE). The deficiency
also reduces the amount of NADPH, which is required for the formation of nitric
oxide (NO). Although female carriers can have a mild form of G6PD deficiency
(dependent on the degree of inactivation of the unaffected X chromosome),
homozygous females have been described; in these females there is co-incidence of
a rare immune disorder termed chronic granulomatous disease (CGD).